{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:57:59Z","timestamp":1790351879013,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.4158\/ep13414.or","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T21:13:14Z","timestamp":1395177194000},"page":"855-863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Practice Patterns in Screening for Metabolic Disease in Women with PCOS of Diverse Race-Ethnic Backgrounds"],"prefix":"10.1016","volume":"20","author":[{"given":"Melanie M.","family":"Mott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole R.","family":"Kitos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea D.","family":"Coviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP13414.OR_bb0005","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP13414.OR_bb0010","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod."},{"key":"10.4158\/EP13414.OR_bb0015","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/MED.0b013e32835a000e","article-title":"Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome","volume":"19","author":"Huang","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"key":"10.4158\/EP13414.OR_bb0020","first-page":"1","article-title":"Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines","volume":"56","author":"Carmina","year":"2004","journal-title":"Minerva Ginecol."},{"key":"10.4158\/EP13414.OR_bb0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod."},{"key":"10.4158\/EP13414.OR_bb0030","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP13414.OR_bb0035","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP13414.OR_bb0040","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/er.2012-1003","article-title":"Cardiometabolic aspects of the polycystic ovary syndrome","volume":"33","author":"Randeva","year":"2012","journal-title":"Endocrine Rev."},{"key":"10.4158\/EP13414.OR_bb0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.OGX.0000109523.25076.E2","article-title":"Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls","volume":"59","author":"Legro","year":"2004","journal-title":"Obstet Gynecol Surv."},{"key":"10.4158\/EP13414.OR_bb0050","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1210\/jc.2006-2725","article-title":"Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance","volume":"92","author":"Carmina","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP13414.OR_bb0055","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0015-0282(03)00265-6","article-title":"Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome","volume":"79","author":"Yildirim","year":"2003","journal-title":"Fertil Steril."},{"key":"10.4158\/EP13414.OR_bb0060","doi-asserted-by":"crossref","first-page":"E1579","DOI":"10.1210\/jc.2012-2043","article-title":"Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement","volume":"97","author":"Golden","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP13414.OR_bb0065","first-page":"e6","article-title":"Heart disease and stroke statistics--2013 update: a report from the American Heart Association","volume":"127","author":"Go","year":"2013","journal-title":"Circulation."},{"key":"10.4158\/EP13414.OR_bb0070","first-page":"126","article-title":"American Association of Clinical Endocrinologists Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome","volume":"11","author":"American Association of Clinical Endocrinologists Polycystic Ovary Syndrome Writing Committee","year":"2005","journal-title":"Endocr Pract."},{"key":"10.4158\/EP13414.OR_bb0075","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP13414.OR_bb0080","doi-asserted-by":"crossref","first-page":"II46","DOI":"10.1097\/00005650-200108002-00003","article-title":"Successes and failures in the implementation of evidence-based guidelines for clinical practice","volume":"39","author":"Grol","year":"2001","journal-title":"Med Care."},{"key":"10.4158\/EP13414.OR_bb0085","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(03)14546-1","article-title":"From best evidence to best practice: effective implementation of change in patients\u2019 care","volume":"362","author":"Grol","year":"2003","journal-title":"Lancet."},{"key":"10.4158\/EP13414.OR_bb0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6947-8-38","article-title":"Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review","volume":"8","author":"Francke","year":"2008","journal-title":"BMC Med Inform Decis Mak."},{"key":"10.4158\/EP13414.OR_bb0095","doi-asserted-by":"crossref","first-page":"447","DOI":"10.7326\/0003-4819-85-4-447","article-title":"Menopause and risk of cardiovascular disease: the Framingham study","volume":"85","author":"Kannel","year":"1976","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP13414.OR_bb0100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril."},{"key":"10.4158\/EP13414.OR_bb0105","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2337\/db11-1360","article-title":"Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study","volume":"61","author":"Gambineri","year":"2012","journal-title":"Diabetes."},{"key":"10.4158\/EP13414.OR_bb0110","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"Suppl 1","key":"10.4158\/EP13414.OR_bb0115","first-page":"S11","volume":"33","year":"2010","journal-title":"Diabetes Care."},{"key":"10.4158\/EP13414.OR_bb0185","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ncpendmet0755","volume":"4","author":"Hoffman","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab."},{"key":"10.4158\/EP13414.OR_bb0120","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and metaanalysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"key":"10.4158\/EP13414.OR_bb0125","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.2337\/diabetes.54.12.3541","article-title":"Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients","volume":"54","author":"Targher","year":"2005","journal-title":"Diabetes."},{"key":"10.4158\/EP13414.OR_bb0130","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology."},{"key":"10.4158\/EP13414.OR_bb0135","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2007.06.009","article-title":"Need for liver evaluation in polycystic ovary syndrome","volume":"47","author":"Carmina","year":"2007","journal-title":"J Hepatol."},{"key":"10.4158\/EP13414.OR_bb0140","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2007.04.012","article-title":"Nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"47","author":"Cerda","year":"2007","journal-title":"J Hepatol."},{"key":"10.4158\/EP13414.OR_bb0145","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cgh.2006.10.010","article-title":"Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"5","author":"Gambarin-Gelwan","year":"2007","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.4158\/EP13414.OR_bb0150","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2009-2698","article-title":"Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome","volume":"95","author":"Chen","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP13414.OR_bb0155","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejogrb.2012.03.007","article-title":"Polycystic ovary syndrome and diabetes screening: a survey of gynecologists and reproductive endocrinologists","volume":"162","author":"Abdel-Rahman","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"10.4158\/EP13414.OR_bb0160","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP13414.OR_bb0165","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.2337\/diacare.28.7.1808","article-title":"Rarer than a blue moon: the use of a diagnostic code for the metabolic syndrome in the U.S","volume":"28","author":"Ford","year":"2005","journal-title":"Diabetes Care."},{"key":"10.4158\/EP13414.OR_bb0170","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome","volume":"91","author":"Lo","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP13414.OR_bb0175","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ajog.2009.12.020","article-title":"Racial and ethnic disparities in reproductive endocrinology and infertility","volume":"202","author":"Huddleston","year":"2010","journal-title":"Am J Obstet Gynecol."},{"key":"10.4158\/EP13414.OR_bb0180","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2005-0628","article-title":"Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span","volume":"90","author":"Azziz","year":"2005","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20422244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20422244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/G679283H272M2W48.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:58:06Z","timestamp":1761515886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20422244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1530891X20422244"],"URL":"https:\/\/doi.org\/10.4158\/ep13414.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practice Patterns in Screening for Metabolic Disease in Women with PCOS of Diverse Race-Ethnic Backgrounds","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP13414.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}